Skip to main content

Table 2 Reduction of migraine days

From: Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial

Days with migraine (SD)

Verum

Placebo

P value

 

N = 55

N = 57

 

Baseline

6.2 (1.95)

6.5 (1.78)

-

Treatment 1st month

5.0 (3.39)

5.7 (3.03)

0.37

Treatment 2nd month

4.8 (3.29)

5.5 (3.01)

0.39

Treatment 3rd month

4.4 (2.99)

5.2 (3.22)

0.23